Report Detail

Pharma & Healthcare Global Topical Hemostatic Agents Market Research Report 2021

  • RnM3402439
  • |
  • 15 February, 2021
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others

Segment by Application
Hospitals
Surgical Centers
Nursing Homes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies


1 Topical Hemostatic Agents Market Overview

  • 1.1 Product Overview and Scope of Topical Hemostatic Agents
  • 1.2 Topical Hemostatic Agents Segment by Type
    • 1.2.1 Global Topical Hemostatic Agents Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Gelation Sponge
    • 1.2.3 Oxidized Regenerated Cellulose Based Hemostats
    • 1.2.4 Others
  • 1.3 Topical Hemostatic Agents Segment by Application
    • 1.3.1 Topical Hemostatic Agents Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Surgical Centers
    • 1.3.4 Nursing Homes
  • 1.4 Global Topical Hemostatic Agents Market Size Estimates and Forecasts
    • 1.4.1 Global Topical Hemostatic Agents Revenue 2016-2027
    • 1.4.2 Global Topical Hemostatic Agents Sales 2016-2027
    • 1.4.3 Topical Hemostatic Agents Market Size by Region: 2016 Versus 2021 Versus 2027

2 Topical Hemostatic Agents Market Competition by Manufacturers

  • 2.1 Global Topical Hemostatic Agents Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Topical Hemostatic Agents Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Topical Hemostatic Agents Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Topical Hemostatic Agents Manufacturing Sites, Area Served, Product Type
  • 2.5 Topical Hemostatic Agents Market Competitive Situation and Trends
    • 2.5.1 Topical Hemostatic Agents Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Topical Hemostatic Agents Players Market Share by Revenue
    • 2.5.3 Global Topical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Topical Hemostatic Agents Retrospective Market Scenario by Region

  • 3.1 Global Topical Hemostatic Agents Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Topical Hemostatic Agents Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Topical Hemostatic Agents Market Facts & Figures by Country
    • 3.3.1 North America Topical Hemostatic Agents Sales by Country
    • 3.3.2 North America Topical Hemostatic Agents Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Topical Hemostatic Agents Market Facts & Figures by Country
    • 3.4.1 Europe Topical Hemostatic Agents Sales by Country
    • 3.4.2 Europe Topical Hemostatic Agents Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Topical Hemostatic Agents Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Topical Hemostatic Agents Sales by Region
    • 3.5.2 Asia Pacific Topical Hemostatic Agents Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Topical Hemostatic Agents Market Facts & Figures by Country
    • 3.6.1 Latin America Topical Hemostatic Agents Sales by Country
    • 3.6.2 Latin America Topical Hemostatic Agents Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Topical Hemostatic Agents Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Topical Hemostatic Agents Sales by Country
    • 3.7.2 Middle East and Africa Topical Hemostatic Agents Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Topical Hemostatic Agents Historic Market Analysis by Type

  • 4.1 Global Topical Hemostatic Agents Sales Market Share by Type (2016-2021)
  • 4.2 Global Topical Hemostatic Agents Revenue Market Share by Type (2016-2021)
  • 4.3 Global Topical Hemostatic Agents Price by Type (2016-2021)

5 Global Topical Hemostatic Agents Historic Market Analysis by Application

  • 5.1 Global Topical Hemostatic Agents Sales Market Share by Application (2016-2021)
  • 5.2 Global Topical Hemostatic Agents Revenue Market Share by Application (2016-2021)
  • 5.3 Global Topical Hemostatic Agents Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Ethicon
    • 6.1.1 Ethicon Corporation Information
    • 6.1.2 Ethicon Description and Business Overview
    • 6.1.3 Ethicon Topical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Ethicon Product Portfolio
    • 6.1.5 Ethicon Recent Developments/Updates
  • 6.2 Pfizer
    • 6.2.1 Pfizer Corporation Information
    • 6.2.2 Pfizer Description and Business Overview
    • 6.2.3 Pfizer Topical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Pfizer Product Portfolio
    • 6.2.5 Pfizer Recent Developments/Updates
  • 6.3 Baxter International
    • 6.3.1 Baxter International Corporation Information
    • 6.3.2 Baxter International Description and Business Overview
    • 6.3.3 Baxter International Topical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Baxter International Product Portfolio
    • 6.3.5 Baxter International Recent Developments/Updates
  • 6.4 C. R. Bard
    • 6.4.1 C. R. Bard Corporation Information
    • 6.4.2 C. R. Bard Description and Business Overview
    • 6.4.3 C. R. Bard Topical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 C. R. Bard Product Portfolio
    • 6.4.5 C. R. Bard Recent Developments/Updates
  • 6.5 The Medicines Company
    • 6.5.1 The Medicines Company Corporation Information
    • 6.5.2 The Medicines Company Description and Business Overview
    • 6.5.3 The Medicines Company Topical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 The Medicines Company Product Portfolio
    • 6.5.5 The Medicines Company Recent Developments/Updates
  • 6.6 Anika Therapeutics
    • 6.6.1 Anika Therapeutics Corporation Information
    • 6.6.2 Anika Therapeutics Description and Business Overview
    • 6.6.3 Anika Therapeutics Topical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Anika Therapeutics Product Portfolio
    • 6.6.5 Anika Therapeutics Recent Developments/Updates
  • 6.7 Advanced Medical Solutions
    • 6.6.1 Advanced Medical Solutions Corporation Information
    • 6.6.2 Advanced Medical Solutions Description and Business Overview
    • 6.6.3 Advanced Medical Solutions Topical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Advanced Medical Solutions Product Portfolio
    • 6.7.5 Advanced Medical Solutions Recent Developments/Updates
  • 6.8 Integra LifeSciences
    • 6.8.1 Integra LifeSciences Corporation Information
    • 6.8.2 Integra LifeSciences Description and Business Overview
    • 6.8.3 Integra LifeSciences Topical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Integra LifeSciences Product Portfolio
    • 6.8.5 Integra LifeSciences Recent Developments/Updates
  • 6.9 B Braun Melsungen
    • 6.9.1 B Braun Melsungen Corporation Information
    • 6.9.2 B Braun Melsungen Description and Business Overview
    • 6.9.3 B Braun Melsungen Topical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 B Braun Melsungen Product Portfolio
    • 6.9.5 B Braun Melsungen Recent Developments/Updates
  • 6.10 Gelita Medical
    • 6.10.1 Gelita Medical Corporation Information
    • 6.10.2 Gelita Medical Description and Business Overview
    • 6.10.3 Gelita Medical Topical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Gelita Medical Product Portfolio
    • 6.10.5 Gelita Medical Recent Developments/Updates
  • 6.11 Equimedical
    • 6.11.1 Equimedical Corporation Information
    • 6.11.2 Equimedical Topical Hemostatic Agents Description and Business Overview
    • 6.11.3 Equimedical Topical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Equimedical Product Portfolio
    • 6.11.5 Equimedical Recent Developments/Updates
  • 6.12 Vascular Solutions
    • 6.12.1 Vascular Solutions Corporation Information
    • 6.12.2 Vascular Solutions Topical Hemostatic Agents Description and Business Overview
    • 6.12.3 Vascular Solutions Topical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Vascular Solutions Product Portfolio
    • 6.12.5 Vascular Solutions Recent Developments/Updates
  • 6.13 Marine Polymer Technologies
    • 6.13.1 Marine Polymer Technologies Corporation Information
    • 6.13.2 Marine Polymer Technologies Topical Hemostatic Agents Description and Business Overview
    • 6.13.3 Marine Polymer Technologies Topical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Marine Polymer Technologies Product Portfolio
    • 6.13.5 Marine Polymer Technologies Recent Developments/Updates

7 Topical Hemostatic Agents Manufacturing Cost Analysis

  • 7.1 Topical Hemostatic Agents Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Topical Hemostatic Agents
  • 7.4 Topical Hemostatic Agents Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Topical Hemostatic Agents Distributors List
  • 8.3 Topical Hemostatic Agents Customers

9 Topical Hemostatic Agents Market Dynamics

  • 9.1 Topical Hemostatic Agents Industry Trends
  • 9.2 Topical Hemostatic Agents Growth Drivers
  • 9.3 Topical Hemostatic Agents Market Challenges
  • 9.4 Topical Hemostatic Agents Market Restraints

10 Global Market Forecast

  • 10.1 Topical Hemostatic Agents Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Topical Hemostatic Agents by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Topical Hemostatic Agents by Type (2022-2027)
  • 10.2 Topical Hemostatic Agents Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Topical Hemostatic Agents by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Topical Hemostatic Agents by Application (2022-2027)
  • 10.3 Topical Hemostatic Agents Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Topical Hemostatic Agents by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Topical Hemostatic Agents by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    Summary:
    Get latest Market Research Reports on Topical Hemostatic Agents . Industry analysis & Market Report on Topical Hemostatic Agents is a syndicated market report, published as Global Topical Hemostatic Agents Market Research Report 2021. It is complete Research Study and Industry Analysis of Topical Hemostatic Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,296.80
    3,445.20
    4,593.60
    2,679.60
    4,019.40
    5,359.20
    438,741.00
    658,111.50
    877,482.00
    241,773.00
    362,659.50
    483,546.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report